Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study
Titel:
Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study
Auteur:
Krebs, Matthew G. Delord, Jean-Pierre Jeffry Evans, Thomas R. De Jonge, Maja Kim, Sang-We Meurer, Marie Postel-Vinay, Sophie Lee, Jong-Seok Angell, Helen K. Rocher-Ros, Vidalba Meyer, Kassondra Ah-See, Mei-Lin Herbolsheimer, Pia Lai, Zhongwu Nunes, Ana Domchek, Susan M.